Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS

ANTIRHEUMATIC AGENTS

  • You have access
    Expert Consensus on a Set of Outcomes to Assess the Effectiveness of Biologic Treatment in Psoriatic Arthritis: The MERECES Study
    Juan D. Cañete, Joan M. Nolla, Ruben Queiro, Miguel J. Rodríguez, Miguel Ruiz and Luis Lizán for the MERECES Working Group
    The Journal of Rheumatology November 1 2020, 47 (11) 1637-1643; DOI: https://doi.org/10.3899/jrheum.191056
  • You have access
    Response to Early-onset Pamidronate Treatment in Chronic Nonbacterial Osteomyelitis: A Retrospective Single-center Study
    Caroline Marie Andreasen, Anne Grethe Jurik, Mia B. Glerup, Christian Høst, Birgitte T. Mahler, Ellen-Margrethe Hauge and Troels Herlin
    The Journal of Rheumatology November 1 2019, 46 (11) 1515-1523; DOI: https://doi.org/10.3899/jrheum.181254
  • You have access
    Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease Activity
    Leslie R. Harrold, Bradley S. Stolshek, Sabrina Rebello, David H. Collier, Alex Mutebi, Sally W. Wade, Wendi Malley, Jeffrey D. Greenberg and Carol J. Etzel
    The Journal of Rheumatology January 1 2018, 45 (1) 78-82; DOI: https://doi.org/10.3899/jrheum.161567
  • You have access
    The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate
    Matt D. Stevenson, Allan J. Wailoo, Jonathan C. Tosh, Monica Hernandez-Alava, Laura A. Gibson, John W. Stevens, Rachel J. Archer, Emma L. Simpson, Emma S. Hock, Adam Young and David L. Scott
    The Journal of Rheumatology July 1 2017, 44 (7) 973-980; DOI: https://doi.org/10.3899/jrheum.160941
  • You have access
    Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study
    Sayoko Harada, Ryoko Sakai, Fumio Hirano, Nobuyuki Miyasaka and Masayoshi Harigai for The REAL Study Group
    The Journal of Rheumatology July 1 2017, 44 (7) 988-995; DOI: https://doi.org/10.3899/jrheum.161196
  • You have access
    Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD
    Francisco Espinoza, Pierre Le Blay and Bernard Combe
    The Journal of Rheumatology June 1 2017, 44 (6) 844-849; DOI: https://doi.org/10.3899/jrheum.150457
  • You have access
    Safety of Biologic and Nonbiologic Disease-modifying Antirheumatic Drug Therapy in Veterans with Rheumatoid Arthritis and Hepatitis C Virus Infection
    Mary Jane Burton, Jeffrey R. Curtis, Shuo Yang, Lang Chen, Jasvinder A. Singh, Ted R. Mikuls, Kevin L. Winthrop and John W. Baddley
    The Journal of Rheumatology May 1 2017, 44 (5) 565-570; DOI: https://doi.org/10.3899/jrheum.160983
  • You have access
    Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study
    Kazuki Yoshida, Helga Radner, Maria D. Mjaavatten, Jeffrey D. Greenberg, Arthur Kavanaugh, Mitsumasa Kishimoto, Kazuo Matsui, Masato Okada, George Reed, Yukihiko Saeki, Shigeto Tohma, Joel Kremer and Daniel H. Solomon
    The Journal of Rheumatology December 1 2015, 42 (12) 2238-2246; DOI: https://doi.org/10.3899/jrheum.150240
  • You have access
    Rheumatoid Arthritis: Trends in Antirheumatic Drug Use, C-reactive Protein Levels, and Surgical Burden
    Alma B. Pedersen, Anil Mor, Frank Mehnert, Reimar W. Thomsen, Søren P. Johnsen and Mette Nørgaard
    The Journal of Rheumatology December 1 2015, 42 (12) 2247-2254; DOI: https://doi.org/10.3899/jrheum.141297
  • You have access
    Effectiveness and Drug Survival of TNF Inhibitors in the Treatment of Ankylosing Spondylitis: A Prospective Cohort Study
    Arto V. Heinonen, Kalle J. Aaltonen, Jaana T. Joensuu, Jukka P. Lähteenmäki, Marja I. Pertovaara, Matti K. Romu, Hanna E. Hirvonen, Aki K. Similä, Marja L. Blom and Dan C. Nordström
    The Journal of Rheumatology December 1 2015, 42 (12) 2339-2346; DOI: https://doi.org/10.3899/jrheum.150389

Pages

  • Next
  • 1
  • 2

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire